How substance use quietly bleeds businesses dry, and the prevention strategies that can stop it
Key Points:
- A new study estimates that substance use and mental health challenges have cost US employees more than $1 trillion over five years, with individual losses averaging nearly $11,000 per person
- Lost productivity, absenteeism, presenteeism, high turnover, and rising healthcare costs all contribute to the staggering financial toll on American workplaces
- Drug testing expert warns that without prevention-led strategies, businesses will continue absorbing costs that are hiding in plain sight
When a number exceeds a trillion dollars, it signals something significant. A recent study found that substance use and mental health challenges have cost American employees an estimated $1.15 trillion over the past five years, a number that reflects days missed and a steady erosion of productivity, safety, and workforce stability across the country.
At an individual level, that translates to an average loss of $10,968 per person, with 41% of respondents reporting that substance use or mental health issues had directly affected their ability to work.
For businesses, the damage rarely appears as a single line item. It accumulates quietly through reduced output, workplace injuries, insurance claims, turnover, and the cost of replacing trained staff. It shows up in the employee who is present but performing far below capacity, and in the manager who doesn’t flag the problem until it becomes a crisis.
Mona Montanino, President of 12 Panel Now, a U.S.-based provider of workplace drug testing supplies with over eight years of experience helping employers maintain safe and compliant environments, has seen the operational side of this issue up close.
“The trillion-dollar figure isn’t a surprise to anyone working in this space,” says Montanino. “What surprises employers is how much of that cost is sitting inside their own workforce, undetected and unaddressed.”
Below, Montanino breaks down exactly where the losses come from, why existing support structures are falling short, and what employers can start doing today.
What Makes Up the $1 Trillion?
The core contributors are:
- lost productivity, the largest driver
- Absenteeism
- extended sick leave
- injury claims
- healthcare costs
- workforce churn
Presenteeism compounds the problem in ways that are harder to track. Unlike an absence, an employee who shows up impaired or disengaged doesn’t trigger an alert; the loss simply absorbs into the background.
“Presenteeism is where a lot of employers lose money without realizing it,” says Montanino. “The cost accumulates without ever being flagged.”
Healthcare utilization runs higher among employees with substance use issues, pushing up group insurance premiums and increasing workers’ compensation claims. When a workplace injury follows, the downstream costs, including legal exposure, retraining, and lost time, routinely exceed the initial claim itself.
Turnover adds further pressure. Replacing a single employee can cost between half and twice their annual salary, and in the industries carrying the heaviest burden, that cycle rarely stops.
“Construction, transportation, and manufacturing face the sharpest risk,” Montanino notes. “These are environments where impairment reduces output and creates direct safety exposure, and that exposure has a real financial cost.”
The $1 trillion figure is the product of compounding, largely invisible losses that most businesses have no reliable system to measure, rather than single, dramatic events.
Why Workplace Support Isn’t Closing the Gap
Employee Assistance Programs are now standard across many benefits packages, but low participation rates limit their impact. Employees sometimes avoid them out of concern that seeking help will affect how they are perceived or whether they keep their job.
Stigma and underreporting mean that problems don’t surface until they have already escalated. Managers often lack the training to identify early warning signs, and without standardized screening protocols, businesses are largely dependent on visible deterioration before they can act.
“By the time most employers respond, the situation has already cost them significantly,” says Montanino. “A reactive model means you’re always dealing with damage rather than preventing it.”
The structure of most EAP frameworks reinforces this pattern. Positioned as a separate, confidential resource rather than part of a company’s core safety strategy, they infrequently drive early intervention at the scale the problem demands.
Organizations that integrate substance awareness into manager training, onboarding, and regular safety procedures report earlier identification and fewer workplace incidents. The gap between reactive and prevention-led approaches is one of policy and measurable financial outcomes.
“Effective substance management centres on identifying issues early and responding with consistency and support,” Montanino says. “That kind of structured approach is what leads to measurable change.”
Prevention as a Cost-Control Strategy
When drug screening is framed as risk management rather than discipline, it tends to generate stronger organizational buy-in and better results. Early identification matters because substance-related costs grow the longer an issue goes undetected. A screening program that prevents a single injury, legal claim, or replacement cycle pays for itself many times over.
“Testing supplies are a small line item,” says Montanino. “A workplace accident or losing a trained employee is not.”
Employers who combine consistent screening with manager training and accessible support resources report lower overall costs than those relying on testing alone.
“I recommend three immediate steps to all businesses,” explains Montanino. “Firstly, audit the consistency of current screening protocols. Secondly, ensure managers can recognize behavioral indicators of impairment. Finally, confirm that EAP resources are visible and genuinely accessible to staff.”
Mona Montanino, President of 12 Panel Now, comments:
“The economic pressures facing American workers aren’t easing. Inflation, job insecurity, and sustained workforce strain are well-documented contributors to substance use, and there is little to suggest those pressures will diminish over the next five years. For employers, that means the operational risk grows alongside the conditions that drive it.
“Businesses that treat prevention as a budget line to cut during downturns will find themselves absorbing far greater costs on the other side. The employers who come out ahead will be those who build screening, education, and early intervention into their standard operations now, embedding them as long-term safeguards.”
Credit (https://12panelnow.com/).
